CRISPR-Cas9-mediated gene disruption of HIV-1 co-receptors confers broad resistance to infection in human T cells and humanized mice: Molecular Therapy - Methods & Clinical Development
HEK293T Cells Are Heterozygous for CCR5 Delta 32 Mutation | PLOS ONE
CCR5, Delta-32 Mutation and the HIV Infection Pathway - microbewiki
The Strategies and Challenges of CCR5 Gene Editing in Hematopoietic Stem and Progenitor Cells for the Treatment of HIV | SpringerLink
The potential risks of C-C chemokine receptor 5-edited babies in bone development | Bone Research
CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo: Molecular Therapy
Advancing a CCR5 Gene Editing Therapy to Clinical Trial: Overcoming Viral Vector Toxicity | MaxCyte
Recently, the man referred to as the "Dusseldorf patient" became at least the third person to have been “cured of HIV” after a bone marrow transplant carrying a specific HIV-resistant mutation
Co-Receptors: CCR5 -- Understanding HIV
Viruses | Free Full-Text | CCR5: From Natural Resistance to a New Anti-HIV Strategy
CCR5 - Wikipedia
How to find out if you have the CCR5 gene mutation that makes you immune to HIV - Quora
Timeline of CCR5 genetic editing. History of studies uncovering the... | Download Scientific Diagram
CCR5 and CCR5Δ32 in bacterial and parasitic infections: Thinking chemokine receptors outside the HIV box - Ellwanger - 2020 - International Journal of Immunogenetics - Wiley Online Library
Gene-edited stem cells show promise against H | EurekAlert!
The CCR5 gene indicating a 32 bp deletion, which resulted in a... | Download Scientific Diagram
HEK293T Cells Are Heterozygous for CCR5 Delta 32 Mutation | PLOS ONE
CCR5 and CCR5Δ32 in bacterial and parasitic infections: Thinking chemokine receptors outside the HIV box - Ellwanger - 2020 - International Journal of Immunogenetics - Wiley Online Library
TALENs-mediated homozygous CCR5Δ32 mutations endow CD4+ U87 cells with resistance against HIV‑1 infection
CCR5 — Википедија
Frontiers | Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy
Gene Therapy May Thwart HIV | Science | AAAS
Frontiers | Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection
